Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|January 3, 2022
Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid LeukemiaBerna Bou-Tayeh, Vladimir Laletin, Nassim Salem, et al.
Blood|August 11, 2010
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell educationNiklas K Björkström, Peggy Riese, Frank Heuts, et al.
European Journal of Immunology|April 28, 2016
In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantationTadepally Lakshmikanth, Frank Heuts, S S V Jagadeeswara Rao Muvva, et al.
EMBO Molecular Medicine|October 11, 2023
Downregulation of stromal syntenin sustains AML developmentRaphael Leblanc, Rania Ghossoub, Armelle Goubard, et al.
Frontiers in Immunology|May 22, 2018
Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory ActivitiesAude Le Roy, Thomas Prébet, Rémy Castellano, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Cancer Research|October 4, 2017
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid LeukemiaMaria De Grandis, Florence Bardin, Cyril Fauriat, et al.
Oncotarget|September 20, 2019
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Oncotarget|May 27, 2017
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysisAndrea Maul-Pavicic, Samuel C C Chiang, Anne Rensing-Ehl, et al.
Pageof 5